Order visibility at GlobalWafers Inc (環球晶圓) extends into 2024 and its capacity for next year is fully booked, the world’s No. 3 silicon wafer supplier said yesterday.
GlobalWafers is trying to squeeze out extra capacity by increasing production efficiency, but the company is still unable to satisfy customer demand for next year, company chairwoman Doris Hsu (徐秀蘭) told reporters on the sidelines of a ceremony to mark the 41st anniversary of the Hsinchu Science Park (新竹科學園區).
“We have clear order visibility for 2023 and it should be okay into 2024,” Hsu said. “We do not see any signs of things slowing down in 2023 or 2024.”
Photo: Grace Hung, Taipei Times
The firm has received more than NT$100 billion (US$3.6 billion) in orders, Hsu said.
To secure a stable wafer supply, many customers are signing longer supply agreements, from five years in 2007 — when its made-to-order strategy was first introduced — to eight years now, GlobalWafers said.
Although segments have their ups and downs, a weak segment, such as smartphones, is soon offset by the upswing of another segment, such as cars or 5G-related applications, Hsu said.
GlobalWafers said that it expects its factories to remain fully utilized through 2024, mainly because capacity expansion worldwide moves at a snail’s pace.
“The major task of our salespeople is to explain to customers why we can only fulfill 90 percent of their demand,” Hsu said. “GlobalWafers is not the only company in the world that is facing a supply challenge.”
Global shipments of silicon wafers are expected to see annual growth of 6.4 percent next year, 4.6 percent in 2023 and 2.9 percent in 2024, GlobalWafers said.
To expand capacity, GlobalWafers said it would over the next two years invest US$800 million on improving production efficiency at its 12-inch fabs, including those in the US.
Hsu declined to comment on wafer prices, but said that GlobalWafers factors spikes in manufacturing costs into its product pricing.
The cost of transportation and raw materials, including chemicals, have been increasing since the emergence of COVID-19, amid port gridlock, a container shortage and temporary shutdowns at factories.
The company expects the EU’s introduction of a carbon border tax in 2026 to add to its manufacturing costs, as importers and manufacturers outside the EU would have to pay for the carbon emissions linked to the goods and materials they sell in the eurozone, Hsu said.
The US dollar on Friday rose against the euro, but pared gains late in a session that was muddied by quarter-end trading, while riskier commodity-led currencies fell sharply after European inflation hit a record high and US consumer spending increased faster than expected. Although the dollar index was showing its biggest quarterly gain since the first quarter 2015, but was registered its first weekly decline in three weeks. Sterling rose against the dollar after falling earlier in the day. The pound last showed four straight sessions of gains followed by wild declines on concerns about Britain’s plan to slash taxes and pay
SAMSUNG DISTANT SECOND: Top local chip fims served nearly two-thirds of the global market in Q2, while Samsung kept South Korea competitive with its 16.5 percent share Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) remained the world’s largest contract chipmaker in the second quarter of the year with a 53.4 percent share of the global pure-play foundry market, the Taipei-based market information advisory firm TrendForce Corp (集邦科技) said in a research report on Tuesday. Despite TSMC’s market share dipping slightly from 53.6 percent in the first quarter, it was still far ahead of its rivals, TrendForce said. TSMC continued to benefit from emerging technologies, such as high-performance computing devices, the Internet of Things and automotive electronics, as it posted US$18.15 billion in sales in the second quarter, up 3.5 percent
Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale in the country, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to disclose the formula for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place from 2020 to last year, adding that the vaccine maker is still “eager” to sell the product to China. The company had “given up”
PRICE POINT: While overall demand has lagged expectations, higher-priced iPhone 14 Pro models appear to attract more attention than entry-level versions, sources said Apple Inc is backing off plans to increase production of its new iPhones this year after an anticipated surge in demand failed to materialize, people familiar with the matter said. The Cupertino, California-based company has told suppliers to pull back from efforts to increase assembly of the iPhone 14 product family by as many as 6 million units in the second half of this year, said the people, asking not to be named as the plans are not public. Instead, the company would aim to produce 90 million handsets for the period, about the same level as in the second half